CD114 expression mediates melanoma tumor cell growth and treatment resistance

L Zhang, S Agarwal, JM Shohet, PE Zage - Anticancer Research, 2015 - ar.iiarjournals.org
Background/Aim: Melanoma tumor cell sub-populations expressing a variety of specific
molecular markers have been identified. We hypothesized that expression of CD114, the …

[HTML][HTML] CD10-equipped melanoma cells acquire highly potent tumorigenic activity: A plausible explanation of their significance for a poor prognosis

J Oba, T Nakahara, A Hashimoto-Hachiya, M Liu… - PloS one, 2016 - journals.plos.org
CD10 has been widely used in cancer diagnosis. We previously demonstrated that its
expression in melanoma increased with tumor progression and predicted poor patient …

Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma

J Oba, T Nakahara, S Hayashida, M Kido, L Xie… - Journal of the American …, 2011 - Elsevier
BACKGROUND: CD10 expression in malignant melanoma (MM) has been reported to
increase according to tumor progression and metastasis; however, its association with …

CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans

M Thomas-Pfaab, JP Annereau, C Munsch… - Journal of …, 2013 - Elsevier
BACKGROUND: No biological or molecular marker of primary melanoma tumor cells has
been shown to predict clinical outcome in melanoma. OBJECTIVE: To determine whether …

Identification of CD24 as a marker for tumorigenesis of melanoma

MR Tang, JY Guo, D Wang, N Xu - OncoTargets and therapy, 2018 - Taylor & Francis
Objective Cutaneous melanoma (CM) is a common skin cancer. Surgery is still the primary
treatment for CM, as melanoma is resistant to chemotherapy. In the recent years, it has been …

[HTML][HTML] The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma

ML Gauci, J Giustiniani, C Lepelletier, C Garbar… - Cancer Immunology …, 2022 - Springer
Melanoma is responsible for 90% of skin cancer-related deaths. Major therapeutic advances
have led to a considerable improvement in the prognosis of patients, with the development …

[HTML][HTML] CD271 is an imperfect marker for melanoma initiating cells

Y Cheli, VF Bonnazi, A Jacquel, M Allegra… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Understanding the molecular and cellular processes underlying melanoma plasticity and
heterogeneity is of paramount importance to improve the efficiency of current treatment and …

[HTML][HTML] CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression

N Bilalovic, B Sandstad, R Golouh, JM Nesland… - Modern Pathology, 2004 - Elsevier
CD10 antigen is a 100-kDa-cell surface zinc metalloendopeptidase expressed in a variety of
normal and neoplastic lymphoid and nonlymphoid tissues including melanomas. It was …

[HTML][HTML] Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions

F Talebian, JQ Liu, Z Liu, M Khattabi, Y He, R Ganju… - PloS one, 2012 - journals.plos.org
CD200 is a cell surface glycoprotein that functions through engaging CD200 receptor on
cells of the myeloid lineage and inhibits their functions. Expression of CD200 has been …

[PDF][PDF] Antibody therapy targeting CD47 and CD271 effectively suppresses melanoma metastasis in patient-derived xenografts

M Ngo, A Han, A Lakatos, D Sahoo, SJ Hachey… - Cell reports, 2016 - cell.com
The high rate of metastasis and recurrence among melanoma patients indicates the
existence of cells within melanoma that have the ability to both initiate metastatic programs …